RepliCel

RepliCel LIfe Sciences Inc.
Founder
  • Rolf Hoffmann
  • Kevin McElwee
Headquarters Vancouver, British Columbia, Canada
Key people
  • David Hall (CEO)
Number of employees
 15 FTE (2015)
Website www.replicel.com
Footnotes / references
[1][2]

RepliCel Life Sciences is a Canadian regenerative medicine company based in Vancouver, British Columbia.[1] The company focuses on development of cell therapies using a patient's own cells (autologous cell therapy).[1] The company has treatment development activities targeting chronic tendon injuries which have failed to heal properly,[3] and hair restoration.[2] The company's expertise lies in isolation and exploitation of different cell populations found in the human hair follicle.[1]

The company's business model is focused on establishing proof-of-concept for treatments leading to acquisition by a larger company.[2] An alternative business model has been reported which does not involve acquisition but rather partnership where technologies and methods are licensed to a partner which will commercialize them.[1]

References

  1. 1 2 3 4 5 Dutton, Gail (15 April 2015). "Cell Therapy Is "Hair Raising" in a Good Way" (Paper). Genetic Engineering & Biotechnology News. 35 (8): 8&ndash, 9. Retrieved 16 July 2016. (Subscription required (help)).
  2. 1 2 3 Ellis, Erin (30 October 2013). "A cure for baldness? Stem cell researchers race to regenerate follicles from hair resistant to loss". National Post. Toronto. Retrieved 2016-07-15.
  3. ↑ Ilic, Dusko (September 2013). "Industry Update: Latest developments in stem cell research and regenerative medicine". Regenerative Medicine. 8 (5). RepliCel. doi:10.2217/rme.13.56.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.